{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:31:42Z","timestamp":1783971102313,"version":"3.55.0"},"reference-count":28,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"\n Background & objectives:<\/jats:title>\n Studies have shown that apart from hereditary breast carcinomas, breast cancer susceptibility gene 1 (BRCA1<\/jats:italic>) mutations conferring to its loss are seen in sporadic breast carcinomas (SBC) as well. The aim of the present study was to assess BRCA1<\/jats:italic> methylation in females presenting at King George\u2019s Medical University, Lucknow, with SBC by both immunohistochemistry (IHC) and methylation PCR with respect to hormonal profile and various morphological prognostic parameters. The primary objective was to look for the association between BRCA1 protein expression and DNA promoter methylation.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n 81 mastectomy specimens from SBC of invasive breast carcinoma (no special type) were included in this study. After a detailed morphological assessment, formalin fixed paraffin embedded tissue from a representative tumour area was selected for BRCA1 IHC by heat-mediated antigen retrieval under high pH and DNA extraction and further bisulphate treatment. BRCA1<\/jats:italic> was studied for methylation by methylated and unmethylated PCR-specific primers.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n BRCA1<\/jats:italic> promoter methylation was present in 42\/81 (51.9%) participants, with significant BRCA1 protein loss (72.7%; P<\/jats:italic>=0.002). A significant association between BRCA1 loss and hormonal profile was found (P<\/jats:italic>=0.001); maximum in triple negative breast carcinoma (TNBC) (72%; 18\/25). Most of the TNBC also harboured methylation (68%). Although not significant grade II and III tumours, lymph vascular invasion, ductal carcinoma in situ<\/jats:italic>, and nodal metastasis (\u22653) were seen in a higher percentage in methylated tumours. Mortality in SBC was significantly associated with BRCA1<\/jats:italic> loss (30.3%; P<\/jats:italic>=0.024).<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Study results highlight the concept of \u201cBRCAness\u201d in SBC as well. Hence, we can confer that identification of BRCA1<\/jats:italic> loss in SBC can make it a perfect candidate for poly ADP-ribose polymerase inhibitors or cisplatin-based therapy like hereditary ones.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_4605_20","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T02:31:54Z","timestamp":1691375514000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["BRCA1 promoter methylation & its immunohistochemical correlation in sporadic breast cancer"],"prefix":"10.25259","volume":"158","author":[{"given":"Fatima","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malti Kumari","family":"Maurya","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, A.N. College, Magadh University, Bodh Gaya, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorva","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulranjan","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav Arun","family":"Sonkar","sequence":"additional","affiliation":[{"name":"Department of General Surgery, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu Mati","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"R1-20241212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"The Breast"},{"key":"R2-20241212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"key":"R3-20241212","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.7939630","article-title":"BRCA1 mutations in primary breast and ovarian carcinomas","volume":"266","author":"Futreal","year":"1994","journal-title":"Science"},{"key":"R4-20241212","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.1998.16.1.115","article-title":"Germ-line BRCA1 mutations in women with sporadic breast cancer: Clinical correlations","volume":"16","author":"Garcia-Pati\u00f1o","year":"1998","journal-title":"J Clin Oncol"},{"issue":"15 Suppl","key":"R5-20241212","doi-asserted-by":"crossref","first-page":"e13010","DOI":"10.1200\/JCO.2018.36.15_suppl.e13010","article-title":"Evaluation of BRCA1, STAT-1 and STAT-3 expression in non familial breast cancer from North India: An interim analysis","volume":"36","author":"Gupta","year":"2018","journal-title":"J Clin Oncol"},{"key":"R6-20241212","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng0495-444","article-title":"Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression","volume":"9","author":"Thompson","year":"1995","journal-title":"Nat Genet"},{"key":"R7-20241212","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ajpath.2013.04.033","article-title":"Epigenetic modifications in breast cancer and their role in personalized medicine","volume":"183","author":"Stefansson","year":"2013","journal-title":"Am J Pathol"},{"key":"R8-20241212","doi-asserted-by":"crossref","first-page":"23899","DOI":"10.1074\/jbc.C000276200","article-title":"The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin","volume":"275","author":"Bhattacharyya","year":"2000","journal-title":"J Biol Chem"},{"key":"R9-20241212","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00428-012-1286-z","article-title":"BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression","volume":"461","author":"Bal","year":"2012","journal-title":"Virchows Arch"},{"key":"R10-20241212","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2217\/fon-2016-0289","article-title":"Frequent alterations of homologous recombination repair pathway in primary and chemotolerant breast carcinomas: Clinical importance","volume":"13","author":"Dasgupta","year":"2017","journal-title":"Future Oncol"},{"key":"R11-20241212","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1245\/ASO.2004.02.022","article-title":"Differential association of BRCA1 and BRCA2 genes with some breast cancer-associated genes in early and late onset breast tumors","volume":"11","author":"Chunder","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R12-20241212","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"R13-20241212","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors","volume":"92","author":"Esteller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R14-20241212","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2006.09.002","article-title":"Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours","volume":"43","author":"Butcher","year":"2007","journal-title":"Eur J Cancer"},{"key":"R15-20241212","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/07391102.2010.10507326","article-title":"BRCA1\/BARD1 E3 ubiquitin ligase can modify histones H2A and H2B in the nucleosome particle","volume":"27","author":"Thakar","year":"2010","journal-title":"J Biomol Struct Dyn"},{"key":"R16-20241212","first-page":"3445","article-title":"Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype\/phenotype features with familial breast carcinomas","volume":"30","author":"Rhiem","year":"2010","journal-title":"Anticancer Res"},{"key":"R17-20241212","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12094-012-0968-y","article-title":"Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer","volume":"15","author":"Hasan","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"R18-20241212","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4103\/IJPM.IJPM_201_18","article-title":"Evaluation of CD4+T-cells and CD8+T-cells in triple-negative invasive breast cancer","volume":"61","author":"Jagtap","year":"2018","journal-title":"Indian J Pathol Microbiol"},{"key":"R19-20241212","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of 'BRCAness'in sporadic cancers","volume":"4","author":"Turner","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R20-20241212","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"R21-20241212","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1369\/jhc.4A6544.2005","article-title":"BRCA1 gene expression in breast cancer: A correlative study between real-time RT-PCR and immunohistochemistry","volume":"53","author":"Al-Mulla","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"R22-20241212","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/path.4280","article-title":"Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes","volume":"232","author":"Lehmann","year":"2014","journal-title":"J Pathol"},{"key":"R23-20241212","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng1294-392","article-title":"Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families","volume":"8","author":"Simard","year":"1994","journal-title":"Nat Genet"},{"key":"R24-20241212","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2559.1999.00578.x","article-title":"Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: A correlation with other biological parameters","volume":"34","author":"Lee","year":"1999","journal-title":"Histopathology"},{"key":"R25-20241212","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.32655","article-title":"BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer","volume":"146","author":"Prajzendanc","year":"2020","journal-title":"Int J Cancer"},{"key":"R26-20241212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.humpath.2018.10.004","article-title":"Evaluation of the BRCAness phenotype and its correlations with clinicopathological features in triple-negative breast cancers","volume":"84","author":"Tian","year":"2019","journal-title":"Hum Pathol"},{"key":"R27-20241212","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/0019-509X.175602","article-title":"Delay in presentation to the hospital and factors affecting it in breast cancer patients attending tertiary care center in Central India","volume":"52","author":"Thakur","year":"2015","journal-title":"Indian J Cancer"},{"key":"R28-20241212","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jjco\/hyf020","article-title":"Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers","volume":"32","author":"Miyamoto","year":"2002","journal-title":"Jpn J Clin Oncol"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_4605_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:06:35Z","timestamp":1751497595000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/brca1-promoter-methylation-its-immunohistochemical-correlation-in-sporadic-breast-cancer\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_4605_20","relation":{},"ISSN":["0971-5916","0975-9174"],"issn-type":[{"value":"0971-5916","type":"print"},{"value":"0975-9174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2020-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}